A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial Assessing Efficacy, Safety, Dose-response of Quinagolide Vaginal Rings Administered Sequentially for 8 Menstrual Cycles in Women With Moderate-Severe Endometriosis-related Pain
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2019
Price : $35 *
At a glance
- Drugs Quinagolide (Primary)
- Indications Endometriosis; Pain
- Focus Therapeutic Use
- Acronyms RAQUEL
- Sponsors Ferring Pharmaceuticals
- 26 Apr 2019 Planned End Date changed from 10 Feb 2020 to 1 Apr 2022.
- 26 Apr 2019 Planned primary completion date changed from 11 Sep 2019 to 1 Nov 2021.
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.